Zydus Lifesciences has launched VaxiFlu-4, a WHO-approved quadrivalent influenza vaccine for 2025. Designed to protect against major flu strains, the vaccine ensures broader immunity and reduces the risk of mismatches. Developed at Zydus' Vaccine Technology Centre, it aims to enhance flu prevention and public health in India.